Utah Medical Products, Inc. (UTMD) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

CareDx, Inc.

Tactile Systems Technology, Inc.

Organogenesis Holdings, Inc.

Pulmonx Corp.

Surmodics, Inc.

Orthofix Medical, Inc.

Utah Medical Products, Inc.

Nano-X Imaging Ltd.

Castle Biosciences, Inc.

AirSculpt Technologies, Inc.

OraSure Technologies, Inc.

Why is Utah Medical Products, Inc. ?

High Management Efficiency with a high ROE of 12.53%

Company has a low Debt to Equity ratio (avg) at times

Poor long term growth as Operating profit has grown by an annual rate -3.62% of over the last 5 years

The company has declared Negative results for the last 5 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at USD 11.21 MM
ROCE(HY) Lowest at 9.54%
DEBT-EQUITY RATIO (HY) Highest at 0 %

With ROE of 9.46%, it has a fair valuation with a 1.72 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of 11.69%, its profits have fallen by -18.6%

High Institutional Holdings at 79.23%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Utah Medical Products, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Utah Medical Products, Inc. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Utah Medical Products, Inc.

11.69%

-0.22

23.39%

S&P 500

18.81%

0.98

19.26%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.80%

EBIT Growth (5y)

-3.62%

EBIT to Interest (avg)

16.41

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.71

Sales to Capital Employed (avg)

0.36

Tax Ratio

18.30%

Dividend Payout Ratio

35.17%

Pledged Shares

Institutional Holding

79.23%

ROCE (avg)

42.45%

ROE (avg)

12.53%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.72

EV to EBIT

17.98

EV to EBITDA

14.24

EV to Capital Employed

1.72

EV to Sales

5.32

PEG Ratio

Dividend Yield

108.47%

ROCE (Latest)

9.56%

ROE (Latest)

9.46%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

DIVIDEND PAYOUT RATIO(Y)

Highest at 38.65%

RAW MATERIAL COST(Y)

Fallen by 0.33% (YoY

DIVIDEND PER SHARE(HY)

Highest at USD 10.12

-13What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at USD 11.21 MM

ROCE(HY)

Lowest at 9.54%

DEBT-EQUITY RATIO (HY)

Highest at 0 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 10.12 times

NET SALES(Q)

Lowest at USD 9.04 MM

OPERATING PROFIT(Q)

Lowest at USD 3.19 MM

PRE-TAX PROFIT(Q)

Lowest at USD 3.11 MM

NET PROFIT(Q)

Lowest at USD 2.56 MM

EPS(Q)

Lowest at USD 0.8

Here's what is working for Utah Medical Products, Inc.

Dividend Payout Ratio

Highest at 38.65% and Grown

In each year in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Dividend per share

Highest at USD 10.12

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (USD)

Raw Material Cost

Fallen by 0.33% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Utah Medical Products, Inc.

Operating Cash Flow

Lowest at USD 11.21 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Debt-Equity Ratio

Highest at 0 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Net Sales

Lowest at USD 9.04 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Operating Profit

Lowest at USD 3.19 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit

Lowest at USD 3.11 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD 2.56 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

EPS

Lowest at USD 0.8

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Debtors Turnover Ratio

Lowest at 10.12 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio